GATA2変異性骨髄症候群における拡散したMycobacterium kansasiiとMycobacterium avium複合体の共感染:症例報告

Sabrina Newstead¹, Daniel Montelongo², Salika Shakir³

¹University of Utah Hospital, 30 N 1900 E #4B319, Salt Lake City, UT 84132, USA.

Therapeutic advances in infectious disease

|September 4, 2025

まとめ

この研究では,骨髄分裂症候群とGATA2変異の患者に2つの異なる種で広がった非結核菌感染症の希少な症例が報告されています. 感染はコビメチニブ治療に関連している可能性があります.

科学分野:

感染症
血液学
遺伝学

背景:

骨髄分裂症候群 (MDS) は,クローナル造血幹細胞疾患のグループである.
ゲルムラインGATA2変異は,様々な血液学的悪性腫瘍と免疫不全に関連しています.
コビメチニブは,がん治療に使用されるMEK阻害剤で,標的外効果がある可能性があります.

研究の目的:

拡散した非結核菌 (NTM) 感染症の珍しい症例を報告する.
NTM感染,GATA2変異,コビメチニブ治療の潜在的な相関を調査する.
拡散したNTM感染がもたらす診断と治療の課題を強調する.

主な方法:

MDSとGATA2変異を有する79歳の女性患者の臨床表現と画像検査結果
微生物学的培養のために,スプラクラビキュラリンパ節のコア生検
酸性バチリ (AFB) と真菌病原体に対する血液培養
固体媒介培養を用いたAFB種の特定

主要な成果:

胸部画像では左側ヒラ筋の塊と統合と広範囲にわたるリンパ腺症が明らかにされました
リンパ節と血液のAFB培養は陽性でした.
2つの異なるNTM種, *Mycobacterium avium*複合体と *Mycobacterium kansasii*が特定されました.

結論:

2つの異なるNTM種を含む拡散感染は極めてまれである.
この発見は,コビメチニブ治療,GATA2生殖系統変異,および拡散したNTM感染との潜在的な関連を示唆する.
このケースは,免疫不全の患者,特に遺伝的傾向があり,標的治療を受けている患者における機会性感染症の重要性を強調しています.

キーワード:

GATA2 について M. カンザシーマック症例報告骨髄不形成症候群非結核菌

さらに関連する動画

07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.8K

08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

8.0K

関連する概念動画

01:31

Pulmonary Tuberculosis III

438

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

438

01:28

Pulmonary Tuberculosis II

339

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

339

01:29

Pulmonary Tuberculosis I

321

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

321

01:28

Pulmonary Tuberculosis V

236

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

236

01:26

Pulmonary Tuberculosis IV

196

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

196

関連する実験動画